Sartorius Aktiengesellschaft (SSSGY)

Market Cap	17.39B +7.8%
Revenue (ttm)	4.10B +3.2%
Net Income	187.48M +70.1%
EPS	n/a
Shares Out	n/a
PE Ratio	92.78
Forward PE	39.46
Dividend	0.09 (0.20%)
Ex-Dividend Date	Mar 30, 2026

Volume	809
Open	43.92
Previous Close	n/a
Day's Range	43.03 - 43.95
52-Week Range	37.87 - 50.95
Beta	1.40
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 23, 2026

About SSSGY

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 14,242
• Stock Exchange: OTCMKTS
• Ticker Symbol: SSSGY

Financial Performance

In 2025, SSSGY's revenue was 3.54 billion, an increase of 4.66% compared to the previous year's 3.38 billion. Earnings were 154.90 million, an increase of 84.40%.

Financial numbers in EUR